<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38884994</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>03</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Epidemiologic Features of Recovery From SARS-CoV-2 Infection.</ArticleTitle><Pagination><StartPage>e2417440</StartPage><MedlinePgn>e2417440</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2417440</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2024.17440</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Persistent symptoms and disability following SARS-CoV-2 infection, known as post-COVID-19 condition or "long COVID," are frequently reported and pose a substantial personal and societal burden.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To determine time to recovery following SARS-CoV-2 infection and identify factors associated with recovery by 90 days.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="UNASSIGNED">For this prospective cohort study, standardized ascertainment of SARS-CoV-2 infection was conducted starting in April 1, 2020, across 14 ongoing National Institutes of Health-funded cohorts that have enrolled and followed participants since 1971. This report includes data collected through February 28, 2023, on adults aged 18 years or older with self-reported SARS-CoV-2 infection.</AbstractText><AbstractText Label="EXPOSURE" NlmCategory="UNASSIGNED">Preinfection health conditions and lifestyle factors assessed before and during the pandemic via prepandemic examinations and pandemic-era questionnaires.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">Probability of nonrecovery by 90 days and restricted mean recovery times were estimated using Kaplan-Meier curves, and Cox proportional hazards regression was performed to assess multivariable-adjusted associations with recovery by 90 days.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 4708 participants with self-reported SARS-CoV-2 infection (mean [SD] age, 61.3 [13.8] years; 2952 women [62.7%]), an estimated 22.5% (95% CI, 21.2%-23.7%) did not recover by 90 days post infection. Median (IQR) time to recovery was 20 (8-75) days. By 90 days post infection, there were significant differences in restricted mean recovery time according to sociodemographic, clinical, and lifestyle characteristics, particularly by acute infection severity (outpatient vs critical hospitalization, 32.9 days [95% CI, 31.9-33.9 days] vs 57.6 days [95% CI, 51.9-63.3 days]; log-rank P&#x2009;&lt;&#x2009;.001). Recovery by 90 days post infection was associated with vaccination prior to infection (hazard ratio [HR], 1.30; 95% CI, 1.11-1.51) and infection during the sixth (Omicron variant) vs first wave (HR, 1.25; 95% CI, 1.06-1.49). These associations were mediated by reduced severity of acute infection (33.4% and 17.6%, respectively). Recovery was unfavorably associated with female sex (HR, 0.85; 95% CI, 0.79-0.92) and prepandemic clinical cardiovascular disease (HR, 0.84; 95% CI, 0.71-0.99). No significant multivariable-adjusted associations were observed for age, educational attainment, smoking history, obesity, diabetes, chronic kidney disease, asthma, chronic obstructive pulmonary disease, or elevated depressive symptoms. Results were similar for reinfections.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">In this cohort study, more than 1 in 5 adults did not recover within 3 months of SARS-CoV-2 infection. Recovery within 3 months was less likely in women and those with preexisting cardiovascular disease and more likely in those with COVID-19 vaccination or infection during the Omicron variant wave.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oelsner</LastName><ForeName>Elizabeth C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yifei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balte</LastName><ForeName>Pallavi P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Norrina B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Center for Epidemiology and Population Health, Northwestern Feinberg School of Medicine, Chicago, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrews</LastName><ForeName>Howard</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carson</LastName><ForeName>April</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Alabama at Birmingham.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cole</LastName><ForeName>Shelley A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Texas Biomed, San Antonio, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coresh</LastName><ForeName>Josef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departments of Medicine and Public Health, NYU Grossman School of Medicine, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couper</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Collaborative Studies Coordinating Center, Department of Biostatistics, University of North Carolina, Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cushman</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Department of Medicine, Larner School of Medicine, University of Vermont, Burlington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daviglus</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Minority Health Research, University of Illinois College of Medicine, Chicago.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demmer</LastName><ForeName>Ryan T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, Department of Quantitative Health Sciences, College of Medicine and Science, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkind</LastName><ForeName>Mitchell S V</ForeName><Initials>MSV</Initials><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>American Heart Association, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Linda C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Psychology, San Diego State University, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howard</LastName><ForeName>Virginia J</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Alabama at Birmingham.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isasi</LastName><ForeName>Carmen R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Judd</LastName><ForeName>Suzanne E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Alabama at Birmingham.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanaya</LastName><ForeName>Alka M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Departments of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kandula</LastName><ForeName>Namratha R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Center for Epidemiology and Population Health, Northwestern Feinberg School of Medicine, Chicago, Illinois.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinney</LastName><ForeName>Gregory L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, University of Colorado Denver.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucharska-Newton</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Environmental Health, University of Kentucky, Lexington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lackland</LastName><ForeName>Daniel T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of South Carolina, Charleston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Joyce S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care, Department of Medicine, University of Colorado, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Make</LastName><ForeName>Barry J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Sleep, Department of Medicine, National Jewish Health, Denver, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Yuan-I</ForeName><Initials>YI</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Mississippi Medical Center, Jackson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murabito</LastName><ForeName>Joanne M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Boston University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norwood</LastName><ForeName>Arnita F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Mississippi Medical Center, Jackson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega</LastName><ForeName>Victor E</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Mayo Clinic, Phoenix, Arizona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pettee Gabriel</LastName><ForeName>Kelley</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, University of Alabama at Birmingham.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Psaty</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Departments of Epidemiology and Medicine, University of Washington, Seattle.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regan</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, National Jewish Health, Denver, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotres-Alvarez</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Collaborative Studies Coordinating Center, Department of Biostatistics, University of North Carolina, Chapel Hill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care, Department of Medicine, University of Colorado, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shikany</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Preventive Medicine, Heersink School of Medicine, University of Alabama at Birmingham.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thyagarajan</LastName><ForeName>Bharat</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tracy</LastName><ForeName>Russell P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Vermont, Burlington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umans</LastName><ForeName>Jason G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>MedStar Health Research Institute, School of Medicine, Georgetown University, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasan</LastName><ForeName>Ramachandran S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>School of Public Health, University of Texas School of Public Health San Antonio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wenzel</LastName><ForeName>Sally E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Allergy and Critical Care, Department of Medicine, University of Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woodruff</LastName><ForeName>Prescott G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Divison of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xanthakis</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Section of Preventive Medicine and Epidemiology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Departments of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Post</LastName><ForeName>Wendy S</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Departments of Medicine and Epidemiology, Johns Hopkins University, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL093009</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 HL165405</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>JAMA Netw Open. 2024 Jul 1;7(7):e2427640. doi: 10.1001/jamanetworkopen.2024.27640</RefSource><PMID Version="1">39018078</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Oelsner reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study and outside the submitted work. Dr Sun reported receiving grants from NIH during the conduct of the study. Dr Balte reported receiving grants from the National Heart, Lung, and Blood Institute (NHLBI) during the conduct of the study. Dr Allen reported receiving grants from NHLBI during the conduct of the study. Dr Carson reported receiving grants from NIH during the conduct of the study and from Amgen outside the submitted work. Prof Coresh reported receiving grants from NIH during the conduct of the study. Dr Couper reported receiving grants from NHLBI during the conduct of the study. Dr Cushman reported receiving grants from NIH during the conduct of the study. Dr Daviglus reported receiving grants from NIH during the conduct of the study. Dr Elkind reported receiving nonfinancial support from the Bristol Myers Squibb-Pfizer Alliance outside the submitted work. Dr Howard reported receiving grants from the National Institute of Neurological Disorders and Stroke, NHLBI, and the National Institute on Aging during the conduct of the study. Dr Kandula reported receiving grants from NHLBI during the conduct of the study and a stipend from the American Diabetes Association for service as an associate editor for <i>Diabetes Care</i>. Dr Lee reported receiving grants from NIH and Pliant Therapeutics; and personal fees from Boehringer Ingelheim, United Therapeutics, Blade Therapeutics, AstraZeneca, Eleven P15, and Elima; and medical advisor fees from the Pulmonary Fibrosis Foundation outside the submitted work. Dr Min reported receiving grants from NIH outside the submitted work. Dr Murabito reported receiving grants from NHLBI during the conduct of the study. Dr Ortega reported data monitoring committee membership with Regeneron and Sanofi outside the submitted work. Dr Pettee Gabriel reported receiving grants from NIH outside the submitted work. Prof Psaty reported steering committee membership of the Yale Open Data Access Project funded by Johnson &amp; Johnson. Dr Regan reported receiving grants from NHLBI during the conduct of the study. Dr Schwartz reported receiving grants from the University of Colorado during the conduct of the study. Dr Shikany reported receiving contract fees from the University of Alabama at Birmingham Coronary Artery Risk Development in Young Adults (CARDIA) Study Coordinating Center during the conduct of the study. Dr Thyagarajan reported receiving grants from NIH during the conduct of the study. Dr Tracy reported receiving grants from NIH during the conduct of the study. Dr Umans reported receiving grants from NIH during the conduct of the study. Dr Vasan reported receiving grants from NIH during the conduct of the study. Dr Wenzel reported receiving grants from NIH during the conduct of the study. Dr Woodruff reported receiving consulting fees from Roche, AstraZeneca, Sanofi, and Regeneron outside the submitted work. Dr Zhang reported receiving grants from NIH during the conduct of the study. Dr Post reported receiving grants from NIH during the conduct of the study. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>17</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>17</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>17</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38884994</ArticleId><ArticleId IdType="pmc">PMC11184459</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.17440</ArticleId><ArticleId IdType="pii">2820087</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group . Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-605. doi:10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 &#x201c;long haulers&#x201d; stump experts. JAMA. 2020;324(14):1381-1383. doi:10.1001/jama.2020.17709</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. World Health Organization ; &#x200e;2021. &#x200e;. Accessed December 7, 2023. https://apps.who.int/iris/handle/10665/345824</Citation></Reference><Reference><Citation>Long COVID: terms &amp; definitions. COVID.gov. Accessed December 7, 2023. https://www.covid.gov/be-informed/longcovid/about#term</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2021;226(9):1593-1607 doi:10.1101/2021.11.15.21266377</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.15.21266377</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick JL, Titus AR, Slocum E, et al. . Population-based estimates of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) prevalence and characteristics. Clin Infect Dis. 2021;73(11):2055-2064. doi:10.1093/cid/ciab408</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab408</ArticleId><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, et al. . Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. J Gen Intern Med. 2022;37(8):1988-1995. doi:10.1007/s11606-022-07523-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07523-3</ArticleId><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Baye F, Baik SH, Zheng Z, McDonald CJ. Prevalence and characteristics of long COVID in elderly patients: an observational cohort study of over 2 million adults in the US. PLoS Med. 2023;20(4):e1004194. doi:10.1371/journal.pmed.1004194</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004194</ArticleId><ArticleId IdType="pmc">PMC10150975</ArticleId><ArticleId IdType="pubmed">37068113</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock MD, Chew RF, Preiss AJ, et al. ; N3C; RECOVER Consortia . Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat Commun. 2023;14(1):2914. doi:10.1038/s41467-023-38388-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38388-7</ArticleId><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461-1467. doi:10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Pal D, et al. . Characteristics and predictors of long COVID among diagnosed cases of COVID-19. PLoS One. 2022;17(12):e0278825. doi:10.1371/journal.pone.0278825</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Oelsner EC, Krishnaswamy A, Balte PP, et al. ; C4R Investigators . Collaborative Cohort of Cohorts for COVID-19 Research (C4R) study: study design. Am J Epidemiol. 2022;191(7):1153-1173. doi:10.1093/aje/kwac032</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwac032</ArticleId><ArticleId IdType="pmc">PMC8992336</ArticleId><ArticleId IdType="pubmed">35279711</ArticleId></ArticleIdList></Reference><Reference><Citation>Horberg MA, Watson E, Bhatia M, et al. . Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort. Nat Commun. 2022;13(1):5822. doi:10.1038/s41467-022-33573-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33573-6</ArticleId><ArticleId IdType="pmc">PMC9556630</ArticleId><ArticleId IdType="pubmed">36224218</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259-264. doi:10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Self-testing at home or anywhere. Centers for Disease Control and Prevention; 2023. Accessed December 7, 2023. https://www.cdc.gov/coronavirus/2019-ncov/testing/self-testing.html</Citation></Reference><Reference><Citation>The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129(4):687-702. doi:10.1093/oxfordjournals.aje.a115184</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a115184</ArticleId><ArticleId IdType="pubmed">2646917</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman GD, Cutter GR, Donahue RP, et al. . CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105-1116. doi:10.1016/0895-4356(88)90080-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(88)90080-7</ArticleId><ArticleId IdType="pubmed">3204420</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao CW, Vasan RS. Cohort profile: the Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol. 2015;44(6):1800-1813. doi:10.1093/ije/dyv337</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv337</ArticleId><ArticleId IdType="pmc">PMC5156338</ArticleId><ArticleId IdType="pubmed">26705418</ArticleId></ArticleIdList></Reference><Reference><Citation>Daviglus ML, Talavera GA, Avil&#xe9;s-Santa ML, et al. . Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308(17):1775-1784. doi:10.1001/jama.2012.14517</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.14517</ArticleId><ArticleId IdType="pmc">PMC3777250</ArticleId><ArticleId IdType="pubmed">23117778</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavange LM, Kalsbeek WD, Sorlie PD, et al. . Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol. 2010;20(8):642-649. doi:10.1016/j.annepidem.2010.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2010.05.006</ArticleId><ArticleId IdType="pmc">PMC2921622</ArticleId><ArticleId IdType="pubmed">20609344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorlie PD, Avil&#xe9;s-Santa LM, Wassertheil-Smoller S, et al. . Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol. 2010;20(8):629-641. doi:10.1016/j.annepidem.2010.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2010.03.015</ArticleId><ArticleId IdType="pmc">PMC2904957</ArticleId><ArticleId IdType="pubmed">20609343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaya AM, Chang A, Schembri M, et al. . Recruitment and retention of US South Asians for an epidemiologic cohort: experience from the MASALA study. J Clin Transl Sci. 2019;3(2-3):97-104. doi:10.1017/cts.2019.371</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cts.2019.371</ArticleId><ArticleId IdType="pmc">PMC6802417</ArticleId><ArticleId IdType="pubmed">31660232</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaya AM, Kandula N, Herrington D, et al. . Mediators of Atherosclerosis in South Asians Living in America (MASALA) study: objectives, methods, and cohort description. Clin Cardiol. 2013;36(12):713-720. doi:10.1002/clc.22219</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.22219</ArticleId><ArticleId IdType="pmc">PMC3947423</ArticleId><ArticleId IdType="pubmed">24194499</ArticleId></ArticleIdList></Reference><Reference><Citation>Bild DE, Bluemke DA, Burke GL, et al. . Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156(9):871-881. doi:10.1093/aje/kwf113</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwf113</ArticleId><ArticleId IdType="pubmed">12397006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee ET, Welty TK, Fabsitz R, et al. . The Strong Heart Study. a study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol. 1990;132(6):1141-1155. doi:10.1093/oxfordjournals.aje.a115757</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a115757</ArticleId><ArticleId IdType="pubmed">2260546</ArticleId></ArticleIdList></Reference><Reference><Citation>North KE, Howard BV, Welty TK, et al. . Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am J Epidemiol. 2003;157(4):303-314. doi:10.1093/aje/kwf208</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwf208</ArticleId><ArticleId IdType="pubmed">12578801</ArticleId></ArticleIdList></Reference><Reference><Citation>Regan EA, Hokanson JE, Murphy JR, et al. . Genetic Epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32-43. doi:10.3109/15412550903499522</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15412550903499522</ArticleId><ArticleId IdType="pmc">PMC2924193</ArticleId><ArticleId IdType="pubmed">20214461</ArticleId></ArticleIdList></Reference><Reference><Citation>Couper D, LaVange LM, Han M, et al. ; SPIROMICS Research Group . Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax. 2014;69(5):491-494. doi:10.1136/thoraxjnl-2013-203897</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2013-203897</ArticleId><ArticleId IdType="pmc">PMC3954445</ArticleId><ArticleId IdType="pubmed">24029743</ArticleId></ArticleIdList></Reference><Reference><Citation>Teague WG, Phillips BR, Fahy JV, et al. . Baseline features of the Severe Asthma Research Program (SARP III) cohort: differences with age. J Allergy Clin Immunol Pract. 2018;6(2):545-554.e4. doi:10.1016/j.jaip.2017.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2017.05.032</ArticleId><ArticleId IdType="pmc">PMC5832534</ArticleId><ArticleId IdType="pubmed">28866107</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard VJ, Cushman M, Pulley L, et al. . The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25(3):135-143. doi:10.1159/000086678</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000086678</ArticleId><ArticleId IdType="pubmed">15990444</ArticleId></ArticleIdList></Reference><Reference><Citation>Oelsner MESA COVID-19 Questionnaire completion guidance. PhenX Toolkit. Accessed December 7, 2023. https://www.phenxtoolkit.org/toolkit_content/PDF/MESA_Questionnaire_Annotated.pdf</Citation></Reference><Reference><Citation>Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Accessed May 31, 2023. https://www.covid19treatmentguidelines.nih.gov/</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Letherby L. What previous COVID-19 waves tell us about the virus now. New York Times. October 23, 2021. Accessed July 21, 2023. https://www.nytimes.com/interactive/2021/10/23/us/covid-surges.html</Citation></Reference><Reference><Citation>Mackey K, Ayers CK, Kondo KK, et al. . Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths: a systematic review. Ann Intern Med. 2021;174(3):362-373. doi:10.7326/M20-6306</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-6306</ArticleId><ArticleId IdType="pmc">PMC7772883</ArticleId><ArticleId IdType="pubmed">33253040</ArticleId></ArticleIdList></Reference><Reference><Citation>Tingley D, Yamamoto T, Hirose K, Keele L, Imai K. mediation: R Package for Causal Mediation Analysis. J Stat Softw. 2014;59(5):1-38. doi:10.18637/jss.v059.i05</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v059.i05</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med. 2009;28(15):1982-1998. doi:10.1002/sim.3618</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3618</ArticleId><ArticleId IdType="pmc">PMC2998703</ArticleId><ArticleId IdType="pubmed">19452569</ArticleId></ArticleIdList></Reference><Reference><Citation>van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1-67. doi:10.18637/jss.v045.i03</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v045.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, et al. ; RECOVER Consortium . Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934-1946. doi:10.1001/jama.2023.8823</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal A. Milder disease with Omicron: is it the virus or the pre-existing immunity? Nat Rev Immunol. 2022;22(2):69-71. doi:10.1038/s41577-022-00678-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00678-4</ArticleId><ArticleId IdType="pmc">PMC8767774</ArticleId><ArticleId IdType="pubmed">35046570</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest. 2022;132(15):e161167. doi:10.1172/JCI161167</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad FB, Anderson RN, Cisewski JA, Sutton PD. Identification of deaths with post-acute sequelae of COVID-19 from death certificate literal text: United States, January 1, 2020&#x2013;June 30, 2022. Vital Statistics Rapid Release report No. 25. Centers for Disease Control and Prevention. December 2022. Accessed December 7, 2023. https://stacks.cdc.gov/view/cdc/121968</Citation></Reference><Reference><Citation>Goldman N, Andrasfay T. Life expectancy loss among Native Americans during the COVID-19 pandemic. Demogr Res. 2022;47:233-246. doi:10.4054/DemRes.2022.47.9</Citation><ArticleIdList><ArticleId IdType="doi">10.4054/DemRes.2022.47.9</ArticleId><ArticleId IdType="pmc">PMC9733701</ArticleId><ArticleId IdType="pubmed">36506651</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Chinn J, De Ferrante M, Kirby KA, Hohmann SF, Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS One. 2021;16(7):e0254066. doi:10.1371/journal.pone.0254066</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254066</ArticleId><ArticleId IdType="pmc">PMC8270145</ArticleId><ArticleId IdType="pubmed">34242273</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham H, de Gruijter NM, Raine C, et al. . Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11(1):6317. doi:10.1038/s41467-020-19741-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19741-6</ArticleId><ArticleId IdType="pmc">PMC7726563</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group . Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761-775. doi:10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. . 1-Year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747-758. doi:10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zang C, Xu Z, et al. . Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med. 2023;29(1):226-235. doi:10.1038/s41591-022-02116-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626-638. doi:10.1038/nri.2016.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28(11):2398-2405. doi:10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Oelsner EC, Balte PP, Cassano PA, et al. . Harmonization of respiratory data from 9 US population-based cohorts: the NHLBI Pooled Cohorts Study. Am J Epidemiol. 2018;187(11):2265-2278. doi:10.1093/aje/kwy139</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwy139</ArticleId><ArticleId IdType="pmc">PMC6211239</ArticleId><ArticleId IdType="pubmed">29982273</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>